Background: In pregnancy, Plasmodium falciparum parasites express the surface antigen VAR2CSA, which mediates adherence of red blood cells to chondroitin sulfate A (CSA) in the placenta. VAR2CSA antibodies are generally acquired during infection in pregnancy and are associated with protection from placental malaria. We observed previously that men and children in Colombia also had antibodies to VAR2CSA, but the origin of these antibodies was unknown. Here, we tested whether infection with Plasmodium vivax is an alternative mechanism of acquisition of VAR2CSA antibodies. Methods: We analyzed sera from nonpregnant Colombians and Brazilians exposed to P. vivax and monoclonal antibodies raised against P. vivax Duffy binding protein (PvDBP). Cross-reactivity to VAR2CSA was characterized by enzyme-linked immunosorbent assay, immunofluorescence assay, and flow cytometry, and antibodies were tested for inhibition of parasite binding to CSA. Results: Over 50% of individuals had antibodies that recognized VAR2CSA. Affinity-purified PvDBP human antibodies and a PvDBP monoclonal antibody recognized VAR2CSA, showing that PvDBP can give rise to cross-reactive antibodies. Importantly, the monoclonal antibody inhibited parasite binding to CSA, which is the primary in vitro correlate of protection from placental malaria. Conclusions: These data suggest that PvDBP induces antibodies that functionally recognize VAR2CSA, revealing a novel mechanism of cross-species immune recognition to falciparum malaria.
Background: In pregnancy, Plasmodium falciparum parasites express the surface antigen VAR2CSA, which mediates adherence of red blood cells to chondroitin sulfate A (CSA) in the placenta. VAR2CSA antibodies are generally acquired during infection in pregnancy and are associated with protection from placental malaria. We observed previously that men and children in Colombia also had antibodies to VAR2CSA, but the origin of these antibodies was unknown. Here, we tested whether infection with Plasmodium vivax is an alternative mechanism of acquisition of VAR2CSA antibodies. Methods: We analyzed sera from nonpregnant Colombians and Brazilians exposed to P. vivax and monoclonal antibodies raised against P. vivax Duffy binding protein (PvDBP). Cross-reactivity to VAR2CSA was characterized by enzyme-linked immunosorbent assay, immunofluorescence assay, and flow cytometry, and antibodies were tested for inhibition of parasite binding to CSA. Results: Over 50% of individuals had antibodies that recognized VAR2CSA. Affinity-purified PvDBPhuman antibodies and a PvDBP monoclonal antibody recognized VAR2CSA, showing that PvDBP can give rise to cross-reactive antibodies. Importantly, the monoclonal antibody inhibited parasite binding to CSA, which is the primary in vitro correlate of protection from placental malaria. Conclusions: These data suggest that PvDBP induces antibodies that functionally recognize VAR2CSA, revealing a novel mechanism of cross-species immune recognition to falciparum malaria.
Authors: Sébastien Igonet; Brigitte Vulliez-Le Normand; Grazyna Faure; Marie-Madeleine Riottot; Clemens H M Kocken; Alan W Thomas; Graham A Bentley Journal: J Mol Biol Date: 2006-12-16 Impact factor: 5.469
Authors: Meghna Desai; Feiko O ter Kuile; François Nosten; Rose McGready; Kwame Asamoa; Bernard Brabin; Robert D Newman Journal: Lancet Infect Dis Date: 2007-02 Impact factor: 25.071
Authors: Kathy A Mangold; Rebecca U Manson; Evelyn S C Koay; Lindsey Stephens; MaryAnn Regner; Richard B Thomson; Lance R Peterson; Karen L Kaul Journal: J Clin Microbiol Date: 2005-05 Impact factor: 5.948
Authors: Francis B Ntumngia; Richard Thomson-Luque; Letícia de Menezes Torres; Karthigayan Gunalan; Luzia H Carvalho; John H Adams Journal: mBio Date: 2016-08-23 Impact factor: 7.867
Authors: Gerald K K Cham; Jonathan Kurtis; John Lusingu; Thor G Theander; Anja T R Jensen; Louise Turner Journal: Malar J Date: 2008-06-12 Impact factor: 2.979
Authors: James Hester; Ernest R Chan; Didier Menard; Odile Mercereau-Puijalon; John Barnwell; Peter A Zimmerman; David Serre Journal: PLoS Negl Trop Dis Date: 2013-12-05
Authors: Catherine J Mitran; Angie Mena; Sedami Gnidehou; Shanna Banman; Eliana Arango; Barbara A S Lima; Hazel Lugo; Aravindhan Ganesan; Ali Salanti; Anthony K Mbonye; Francis Ntumngia; Khaled Barakat; John H Adams; Flora S Kano; Luzia H Carvalho; Amanda E Maestre; Michael F Good; Stephanie K Yanow Journal: mBio Date: 2019-10-08 Impact factor: 7.867